IDEXX Laboratories, Inc. (IDXX)
NASDAQ: IDXX · Real-Time Price · USD
647.09
+0.06 (0.01%)
At close: Aug 29, 2025, 4:00 PM
643.00
-4.09 (-0.63%)
After-hours: Aug 29, 2025, 4:04 PM EDT
IDEXX Laboratories Stock Forecast
Stock Price Forecast
The 7 analysts that cover IDEXX Laboratories stock have a consensus rating of "Buy" and an average price target of $610.71, which forecasts a -5.62% decrease in the stock price over the next year. The lowest target is $475 and the highest is $765.
Price Target: $610.71 (-5.62%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for IDEXX Laboratories stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
Rating | Mar '25 | Apr '25 | May '25 | Jun '25 | Jul '25 | Aug '25 |
---|---|---|---|---|---|---|
Strong Buy | 1 | 1 | 1 | 1 | 1 | 0 |
Buy | 4 | 4 | 4 | 4 | 4 | 4 |
Hold | 3 | 3 | 3 | 3 | 3 | 3 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 8 | 8 | 8 | 8 | 8 | 7 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
Morgan Stanley | Morgan Stanley | Buy Maintains $722 → $765 | Buy | Maintains | $722 → $765 | +18.22% | Aug 15, 2025 |
Piper Sandler | Piper Sandler | Hold Maintains $510 → $700 | Hold | Maintains | $510 → $700 | +8.18% | Aug 11, 2025 |
JP Morgan | JP Morgan | Buy Maintains $550 → $675 | Buy | Maintains | $550 → $675 | +4.31% | Aug 4, 2025 |
Leerink Partners | Leerink Partners | Buy Maintains $580 → $600 | Buy | Maintains | $580 → $600 | -7.28% | Jul 17, 2025 |
Stifel | Stifel | Hold Maintains $510 → $540 | Hold | Maintains | $510 → $540 | -16.55% | Jul 2, 2025 |
Financial Forecast
Revenue This Year
4.32B
from 3.90B
Increased by 10.76%
Revenue Next Year
4.67B
from 4.32B
Increased by 8.15%
EPS This Year
12.85
from 10.67
Increased by 20.47%
EPS Next Year
14.43
from 12.85
Increased by 12.23%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | 4.5B | 4.9B | |||
Avg | 4.3B | 4.7B | |||
Low | 4.1B | 4.4B |
Revenue Growth
Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | 14.8% | 12.8% | |||
Avg | 10.8% | 8.2% | |||
Low | 5.6% | 2.1% |
EPS Forecast
EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | 13.53 | 15.09 | |||
Avg | 12.85 | 14.43 | |||
Low | 12.07 | 13.49 |
EPS Growth
EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | 26.8% | 17.4% | |||
Avg | 20.5% | 12.2% | |||
Low | 13.2% | 4.9% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.